This competitive renewal application is submitted in response to RFA DK-11-022, Silvio O. Conte Digestive Diseases Research Core Centers, requesting continued funding of the Texas Medical Center Digestive Diseases Center (called DDC for simplicity). This Center serves basic and clinical scientists at institutions withi the Texas Medical Center (Baylor College of Medicine, The University of Texas Health Science Center, the MD Anderson Cancer Center) in Houston, TX. Our qualifying Funded Research Base Is $19,872,379 (direct costs) and includes 24 separate awards from NIDDK totaling $7,222,613 (36% of total digestive disease-related funding). Reflecting the goals of these projects, this is a Center for Gastrointestinal Infection and Injury. Institutional resource commitments in space, funds and personnel support this effort. Including new positions in basic and clinical departments from multidisciplinary, independent faculty to establish new research programs. This Center facilitates on-going Digestive Diseases research, promotes translational research between basic and clinical areas, develops new projects, nurtures new investigators, and provides educational activities. Support is requested for an Administrative Core, three Basic Science Cores (Cellular and Molecular Morphology, Functional Genomics and MIcrobiome, Integrative Biology) and one Clinical Core (Study Design and Clinical Research). In addition, our Pilot/Feasibility and Enrichment Programs, including a Career Development Initiative, to support innovative ideas and new Investigators in Digestive Disease research and foster collaborations are a key part of the DDC and have been extremely successful. The Center is a multidiscipllnary group of Investigators of 50 Full Members and 78 Associate Members, Including basic and clinical scientists with proven track records of success, and well-coordinated clinical programs dealing with pediatric and adult Gl patients. Center leaders are senior scientists-administrators experienced in directing interactive, multidisciplinary programs. A large, multi-ethnic population of infants and adults with Digestive Diseases emphasizes a need and opportunities for this Center.

Public Health Relevance

The Texas Medical Center Digestive Diseases Research Core Center serves an integrated and Interdisciplinary research base of basic and clinical investigators performing research to understand gastrointestinal health and disease, and treat and prevent Intestinal, liver and pancreatic disease. Scientific cores, pilot and feasibility grant and enrichment programs promote and facilitate collaborations and stimulate ideas and capabilities to advance science and increase productivity of our interactive research community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK056338-12
Application #
8611910
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (O2))
Program Officer
Podskalny, Judith M,
Project Start
1999-12-01
Project End
2018-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
12
Fiscal Year
2014
Total Cost
$1,174,747
Indirect Cost
$379,128
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Hernaez, Ruben; Kanwal, Fasiha; El-Serag, Hashem B (2018) Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology 68:7-9
Kramer, J R; Puenpatom, A; Erickson, K F et al. (2018) Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system. J Viral Hepat 25:1270-1279
Stewart, Christopher J; Auchtung, Thomas A; Ajami, Nadim J et al. (2018) Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study. PeerJ 6:e4693
Ihekweazu, Faith D; Versalovic, James (2018) Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 356:413-423
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Hu, Liya; Sankaran, Banumathi; Laucirica, Daniel R et al. (2018) Glycan recognition in globally dominant human rotaviruses. Nat Commun 9:2631
Fekry, Baharan; Ribas-Latre, Aleix; Baumgartner, Corrine et al. (2018) Incompatibility of the circadian protein BMAL1 and HNF4? in hepatocellular carcinoma. Nat Commun 9:4349
Robayo-Torres, Claudia C; Diaz-Sotomayor, Marisela; Hamaker, Bruce R et al. (2018) 13C-Labeled-Starch Breath Test in Congenital Sucrase-isomaltase Deficiency. J Pediatr Gastroenterol Nutr 66 Suppl 3:S61-S64
Menon, Renuka T; Shrestha, Amrit Kumar; Barrios, Roberto et al. (2018) Hyperoxia Disrupts Extracellular Signal-Regulated Kinases 1/2-Induced Angiogenesis in the Developing Lungs. Int J Mol Sci 19:
Liu, Yanhong; O'Brien, Jacqueline L; Ajami, Nadim J et al. (2018) Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res 8:1775-1787

Showing the most recent 10 out of 1121 publications